Answers are grounded in this paper and cite their sources.
In accordance with Decree No. 1 of the Chief State Sanitary Doctor of the Russian Federation dated January 11, 2011, "On the Approval of SP 3.1.5.2826-10 'Prevention of HIV Infection'" and Letter No. 30-05/84 of the Ministry of Health of the Samara Region dated March 25, 2015, "On the Organization of Post-Exposure Prophylaxis for Professional HIV Infection of Medical Workers in the Samara Region," the implementation of organizational, therapeutic, preventive, and sanitary-epidemiological measures to prevent occupational HIV infection is the responsibility of the heads of medical organizations, regardless of their legal form, type of ownership, or departmental affiliation [1-4]. The relevance of preventing accidental exposure during various types of work and procedures performed by medical staff is highlighted by the fact that the number of healthcare workers registered for follow-ups at the Samara Regional Center for the Prevention and Control of AIDS and Infectious Diseases after exposure while treating HIV-infected patients has remained consistently high in recent years [5-8]. Pursuant to current legislation, the following measures are conducted to prevent occupational HIV infection: a set of procedures to prevent accidental exposure; training and instruction of medical personnel on immediate actions in the event of an accident; and the recording of injuries and micro-injuries sustained by medical staff in the line of professional duty. An essential element is the organizational component, i.e. appointing, by official order of the medical organization, a specialist responsible for organizing post-exposure prophylaxis for HIV infection among medical workers, determining the scope of the victim's examination, and identifying indications for antiretroviral therapy based on epidemiological history [9-12]. critical aspect is the follow-up of medical workers who have sustained an injury. This is carried out at the place of employment and lasts for 12 months, with mandatory follow-up testing for HIV and parenteral hepatitis at 6 and 12 weeks, and 6 and 12 months. It is also necessary that the individual responsible for overseeing this preventive area be designated by an of ficial order within the medical organization.
No takes yet. Share an insight, caveat, or question.
Babanov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: